Olfactory dysfunction in type 2 diabetes mellitus: An additional manifestation of microvascular disease?

Angiology

Volumn 65, Issue 10, 2014, Pages 869-876

  Gouveri, E ^a   Katotomichelakis, M ^a   Gouveris, H ^a   Danielides, V ^a   Maltezos, E ^a   Papanas, N ^a  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

Author keywords

diabetic complications; olfaction; Sniffin' Sticks; type 2 diabetes mellitus

Indexed keywords

HEMOGLOBIN A1C; ORAL ANTIDIABETIC AGENT;

ADULT; AGE; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETIC MICROANGIOPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; GREECE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NON INSULIN DEPENDENT DIABETES MELLITUS; ODOR IDENTIFICATION; ODOR THRESHOLD; OLFACTORY DISCRIMINATION; SMELLING; SMELLING DISORDER; THRESHOLD DISCRIMINATION IDENTIFICATION SCORE; AGED; COMPLICATION; DIABETIC ANGIOPATHY; MICROCIRCULATION; MIDDLE AGED; OLFACTION DISORDERS; PERCEPTIVE DISCRIMINATION; PERCEPTIVE THRESHOLD; RISK FACTOR;

ADULT; AGE FACTORS; AGED; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DISCRIMINATION (PSYCHOLOGY); FEMALE; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; MALE; MICROCIRCULATION; MIDDLE AGED; OLFACTION DISORDERS; RISK FACTORS; SENSORY THRESHOLDS;

EID: 84908879469     PISSN: 00033197     EISSN: 19401574     Source Type: Journal    
DOI: 10.1177/0003319714520956     Document Type: Article

References (40)

1. Hummel T, Nordin S. Olfactory disorders and their consequences for quality of life. Acta Otolaryngol. 2005 ; 125 (2). 116-121
2. Hoffman HJ, Cruickshanks KJ, Davis B. Perspectives on population-based epidemiological studies of olfactory and taste impairment. Ann N Y Acad Sci. 2009 ; 1170: 514-530
3. Palouzier-Paulignan B, Lacroix MC, Aimé P, et al. Olfaction under metabolic influences. Chem Senses. 2012 ; 37 (9). 769-797
4. Le Floch JP, Le Lièvre G, Labroue M, Paul M, Peynegre R, Perlemuter L. Smell dysfunction and related factors in diabetic patients. Diabetes Care. 1993 ; 16 (6). 934-937
5. Brady S, Lalli P, Midha N, et al. Presence of neuropathic pain may explain poor performances on olfactory testing in diabetes mellitus patients. Chem Senses. 2013 ; 38 (6). 497-507
6. Naka A, Riedl M, Luger A, Hummel T, Mueller CA. Clinical significance of smell and taste disorders in patients with diabetes mellitus. Eur Arch Otorhinolaryngol. 2010 ; 267 (4). 547-550
7. Weinstock RS, Wright HN, Smith DU. Olfactory dysfunction in diabetes mellitus. Physiol Behav. 1993 ; 53 (1). 17-21
8. Gascón C, Santaolalla F, Martínez A, Sánchez Del Rey A. Usefulness of the BAST-24 smell and taste test in the study of diabetic patients: a new approach to the determination of renal function. Acta Otolaryngol. 2013 ; 133 (4). 400-404
9. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004 ; 27 (5). 1047-1053
10. McAdam Marx C. Economic implications of type 2 diabetes management. Am J Manag Care. 2013 ; 19 (8 suppl). S143-148
11. Thawley SE. Disorders of taste and smell. South Med J. 1978 ; 71 (3). 267-270
12. Ponsen MM, Stoffers D, Booij J, van Eck-Smit BL, Wolters ECh, Berendse HW. Idiopathic hyposmia as a preclinical sign of Parkinson's disease. Ann Neurol. 2004 ; 56 (2). 173-181
13. Deems DA, Doty RL, Settle RG, et al. Smell and taste disorders, a study of 750 patients from the University of Pennsylvania Smell and Taste Center. Arch Otolaryngol Head Neck Surg. 1991 ; 117 (5). 519-528
14. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003 ; 289 (19). 2560-2572
15. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Final report. Circulation. 2002 ; 106 (25). 3143-3421
16. http://www.who.int/mediacentre/factsheets/fs317/en/. Accessed on December 16, 2013.
17. Rose GA, Blackburn H Geneva: World Health Organization ; 1968: 98-105.
18. Rooke TW, Hirsch AT, Misra S, et al. 2011 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Peripheral Artery Disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2011 ; 58 (19). 2020-2045
19. Paraskevas KI, Kotsikoris I, Koupidis SA, Giannoukas AD, Mikhailidis DP. Ankle-brachial index: a marker of both peripheral arterial disease and systemic atherosclerosis as well as a predictor of vascular events. Angiology. 2010 ; 61 (6). 521-523
20. Papanas N, Symeonidis G, Mavridis G, et al. Ankle-brachial index: a surrogate marker of microvascular complications in type 2 diabetes mellitus?. Int Angiol. 2007 ; 26 (3). 253-257
21. Young MJ, Boulton AJ, MacLeod AF, Williams DR, Sonksen PH. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia. 1993 ; 36 (2). 150-154
22. Papanas N, Paschos P, Papazoglou D, et al. Accuracy of the Neuropad test for the diagnosis of distal symmetric polyneuropathy in type 2 diabetes. Diabetes Care. 2011 ; 34 (6). 1378-1382
23. Position statement. Diabetes Care. 2003 ; 26 (suppl 1). S94 - S98
24. Fong DS, Aiello L, Gardner TW, et al. Diabetic retinopathy. Diabetes Care. 2003 ; 26 (1). 226-229
25. Hawkins KA, Pearlson GD. Age and gender but not common chronic illnesses predict odor identification in older African Americans. Am J Geriatr Psychiatry. 2011 ; 19 (9). 777-782
26. Hummel T, Sekinger B, Wolf SR, Pauli E, Kobal G. 'Sniffin' sticks': olfactory performance assessed by the combined testing of odor identification, odor discrimination and olfactory threshold. Chem Senses. 1997 ; 22 (1). 39-52
27. Kobal G, Klimek L, Wolfensberger M, et al. Multicenter investigation of 1,036 subjects using a standardized method for the assessment of olfactory function combining tests of odor identification, odor discrimination, and olfactory thresholds. Eur Arch Otorhinolaryngol. 2000 ; 257 (4). 205-211
28. Katotomichelakis M, Balatsouras D, Tripsianis G, et al. The effect of smoking on the olfactory function. Rhinology. 2007 ; 45 (4). 273-280
29. Katotomichelakis M, Balatsouras D, Tripsianis G, Tsaroucha A, Homsioglou E, Danielides V. Normative values of olfactory function testing using the 'sniffin' sticks'. Laryngoscope. 2007 ; 117 (1). 114-120
30. Brämerson A, Johansson L, Ek L, Nordin S, Bende M. Prevalence of olfactory dysfunction: the skövde population-based study. Laryngoscope. 2004 ; 114 (4). 733-737
31. Guthoff M, Tschritter O, Berg D, et al. Effect of genetic variation in Kv1.3 on olfactory function. Diabetes Metab Res Rev. 2009 ; 25 (6). 523-527
32. Murphy C, Schubert CR, Cruickshanks KJ, Klein BE, Klein R, Nondahl DM. Prevalence of olfactory impairment in older adults. JAMA. 2002 ; 288 (18). 2307-2312
33. Vennemann MM, Hummel T, Berger K. The association between smoking and smell and taste impairment in the general population. J Neurol. 2008 ; 255 (8). 1121-1126
34. Schubert CR, Cruickshanks KJ, Klein BE, Klein R, Nondahl DM. Olfactory impairment in older adults: five-year incidence and risk factors. Laryngoscope. 2011 ; 121 (4). 873-878
35. Doty RL, Philip S, Reddy K, Kerr KL. Influences of antihypertensive and antihyperlipidemic drugs on the senses of taste and smell: a review. J Hypertens. 2003 ; 21 (10). 1805-1813
36. Heckmann JG, Höcherl C, Dütsch M, Lang C, Schwab S, Hummel T. Smell and taste disorders in polyneuropathy: a prospective study of chemosensory disorders. Acta Neurol Scand. 2009 ; 120 (4). 258-263
37. Boulton AJ, Malik RA, Arezzo JC, Sosenko JM. Diabetic somatic neuropathies. Diabetes Care. 2004 ; 27 (6). 1458-1486
38. Vileikyte L, Peyrot M, Bundy C, et al. The development and validation of a neuropathy- and foot ulcer-specific quality of life instrument. Diabetes Care. 2003 ; 26 (9). 2549-2555
39. Papanas N, Katsiki N, Papatheodorou K, et al. Peripheral neuropathy is associated with increased serum levels of uric acid in type 2 diabetes mellitus. Angiology. 2011 ; 62 (4). 291-295
40. Papanas N, Demetriou M, Katsiki N, et al. Increased serum levels of uric acid are associated with sudomotor dysfunction in subjects with type 2 diabetes mellitus. Exp Diabetes Res. 2011 ;: 346051